Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: Data from 5 double-blind studies

Jan Volavka, Pal Czobor, Leslie Citrome, Robert D. McQuade, William H. Carson, Dusan Kostic, Sterling Hardy, Ronald Marcus

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective: The objective was to determine the effects of aripiprazole on hostility. Method: A total of 1476 patients diagnosed with DSM-IV schizophrenia or schizoaffective disorder were the subjects in 5 short-term, double-blind studies comparing aripiprazole with placebo; 3 of these studies also included a comparison with haloperidol. The studies were conducted between December 1993 and January 2001. The Positive and Negative Syndrome Scale (PANSS) was the principal outcome measure in these studies. To determine the effect of aripiprazole on hostility, post hoc analyses of the hostility item from the PANSS were conducted for the first 4 weeks of treatment. Results: Aripiprazole was superior to placebo and not significantly different from haloperidol in reducing hostility. Conclusion: Aripiprazole is an effective treatment for hostility in patients with schizophrenia or schizoaffective disorder.

Original languageEnglish
Pages (from-to)1362-1366
Number of pages5
JournalJournal of Clinical Psychiatry
Volume66
Issue number11
DOIs
Publication statusPublished - Nov 2005

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: Data from 5 double-blind studies'. Together they form a unique fingerprint.

  • Cite this